The statement addresses a public issue, specifically the FDA's decision regarding MDMA for the treatment of PTSD, and critiques the influence of pharmaceutical companies. The tone is critical and accusatory, suggesting corporate capture and financial motivations behind the FDA's decision.
- The statement does not directly harm individuals but could contribute to public distrust in regulatory bodies, which may indirectly cause harm. [-1]Principle 1:I will strive to do no harm with my words and actions.
- The statement does not engage in cyberbullying, harassment, or hate speech, but it does make broad accusations against the FDA and pharmaceutical companies without specific evidence.Principle 2:I will respect the privacy and dignity of others and will not engage in cyberbullying, harassment, or hate speech.
- The statement does not promote understanding, empathy, or compassion; it is more focused on criticism and accusation. [-1]Principle 3:I will use my words and actions to promote understanding, empathy, and compassion.
- The statement does not engage in constructive criticism or dialogue; it makes broad, accusatory claims without engaging with opposing viewpoints or providing evidence. [-2]Principle 4:I will engage in constructive criticism and dialogue with those in disagreement and will not engage in personal attacks or ad hominem arguments.
- The statement uses influence to critique a public issue, but it does so in a way that may not be constructive or beneficial to society as it fosters distrust without providing a clear path forward. [-1]Principle 6:I will use my influence for the betterment of society.
- The statement exercises free speech but does so in a manner that may lack responsibility and integrity due to its accusatory nature and lack of evidence. [-1]Principle 7:I will uphold the principles of free speech and use my platform responsibly and with integrity.